Study Recommends Using MRI Screening for Pancreatic Cancer in High-Risk Patients
By MedImaging International staff writers Posted on 14 Apr 2015 |
Image: MRI Image of a Pancreatic Tumor and Intraoperative Sutus (Photo courtesy of JAMA Surgery).
Results of a study that investigated the effectiveness of Magnetic Resonance Imaging for screening high-risk individuals for pancreatic cancer have been published online in the journal JAMA Surgery, on April 8, 2015.
The study was carried out by researchers at the Karolinska Institute (Stockholm, Sweden) and was intended to find a suitable modality for clinical surveillance of individuals with a genetic risk for developing pancreatic cancer. Current screening methods include MRI, Computed Tomography (CT), endoscopic ultrasound, and endoscopic retrograde cholangiopancreatography.
The researchers used an MRI-based surveillance program to study high-risk patients referred to Karolinska University Hospital (Solna, Stockholm, Sweden) between January 1, 2010, and January 31, 2013. The researchers studied 40 patients (16 men, and 24 women) with a mean age of 49.9 years, and a mean length of follow-up of 12.9 months.
The results of the study showed that by using a noninvasive MRI-based screening protocol the researchers were able to detect pancreatic lesions in 40% of the patients. Five of the patients underwent surgery.
Related Links:
Karolinska Institute
Karolinska University Hospital
The study was carried out by researchers at the Karolinska Institute (Stockholm, Sweden) and was intended to find a suitable modality for clinical surveillance of individuals with a genetic risk for developing pancreatic cancer. Current screening methods include MRI, Computed Tomography (CT), endoscopic ultrasound, and endoscopic retrograde cholangiopancreatography.
The researchers used an MRI-based surveillance program to study high-risk patients referred to Karolinska University Hospital (Solna, Stockholm, Sweden) between January 1, 2010, and January 31, 2013. The researchers studied 40 patients (16 men, and 24 women) with a mean age of 49.9 years, and a mean length of follow-up of 12.9 months.
The results of the study showed that by using a noninvasive MRI-based screening protocol the researchers were able to detect pancreatic lesions in 40% of the patients. Five of the patients underwent surgery.
Related Links:
Karolinska Institute
Karolinska University Hospital
Latest MRI News
- Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer